Cumberland Pharmaceuticals Inc. Payments for Repurchase of Redeemable Noncontrolling Interest
Cumberland Pharmaceuticals Inc. (CPIX) reported Payments for Repurchase of Redeemable Noncontrolling Interest of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest · last filed 2022-03-11
- Cumberland Pharmaceuticals Inc. payments for repurchase of redeemable noncontrolling interest for the quarter ending 2021-12-31 was $0.00.
- Cumberland Pharmaceuticals Inc. payments for repurchase of redeemable noncontrolling interest for the quarter ending 2021-09-30 was $0.00.
- Cumberland Pharmaceuticals Inc. payments for repurchase of redeemable noncontrolling interest for the quarter ending 2021-06-30 was $0.00.
- Cumberland Pharmaceuticals Inc. payments for repurchase of redeemable noncontrolling interest for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- Cumberland Pharmaceuticals Inc. payments for repurchase of redeemable noncontrolling interest for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Cumberland Pharmaceuticals Inc. payments for repurchase of redeemable noncontrolling interest for fiscal 2020 was $800.00K.
- Cumberland Pharmaceuticals Inc. payments for repurchase of redeemable noncontrolling interest for fiscal 2017 was $800.00K.
- Cumberland Pharmaceuticals Inc. payments for repurchase of redeemable noncontrolling interest for fiscal 2016 was $0.00.
| Period end | Payments for Repurchase of Redeemable Noncontrolling Interest 3 month | Payments for Repurchase of Redeemable Noncontrolling Interest 6 month | Payments for Repurchase of Redeemable Noncontrolling Interest 9 month | Payments for Repurchase of Redeemable Noncontrolling Interest 12 month | Payments for Repurchase of Redeemable Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $0.00 derived: sum of 2 quarters · filed 2022-03-11 | $0.00 derived: sum of 3 quarters · filed 2022-03-11 | $0.00 10-K · filed 2022-03-11 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | $0.00 derived: sum of 4 quarters · filed 2021-11-12 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $0.00 10-Q · filed 2021-08-13 | $0.00 derived: sum of 3 quarters · filed 2021-08-13 | $0.00 derived: sum of 4 quarters · filed 2021-11-12 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-14 | $0.00 derived: sum of 2 quarters · filed 2021-05-14 | $0.00 derived: sum of 3 quarters · filed 2021-11-12 | $0.00 derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $0.00 derived: sum of 3 quarters · filed 2021-11-12 | $800.00K 10-K · filed 2021-03-12 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $800.00K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $800.00K 10-Q · filed 2021-08-13 | |||
| 2020-03-31 | $800.00K 10-Q · filed 2021-05-14 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $0.00 10-Q · filed 2020-11-13 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $0.00 10-Q · filed 2020-08-14 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-22 | ||||
| 2017-12-31 | $800.00K 10-K · filed 2022-03-11 | $0.00 10-K · filed 2021-03-12 | |||
| 2016-12-31 | $0.00 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |